“…Anti-cancer therapies with cell-death-inducing treatments (Longley et al, 2003;Comella et al, 2009;Carneiro and El-Deiry, 2020) can paradoxically enhance metastasis (Imamura et al, 1990;Wild-Bode et al, 2001;Poth et al, 2010;Vyas et al, 2014;Liu et al, 2015;Middleton et al, 2018;Karagiannis et al, 2019). How this comes about is not clear, although stemness acquisition, anastasis, senescence, and changes in the microen-vironment have all been proposed to contribute (Tang et al, 2012(Tang et al, , 2017Ding et al, 2016;Tato-Costa et al, 2016;Sun et al, 2017Sun et al, , 2020Xu et al, 2018;Middleton et al, 2018;Guillon et al, 2019;Berthenet et al, 2020). Cells surviving acute druginduced apoptosis can display oncogenic traits including epithelial-to-mesenchymal transition (EMT), the modulation of epigenetic remodelers, and limited migration (Tang et al, 2012;Ichim et al, 2015;Tato-Costa et al, 2016;Sun et al, 2017;Seervi et al, 2019;Berthenet et al, 2020).…”